Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 683087, 8 pages
http://dx.doi.org/10.1155/2015/683087
Research Article

Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns

1Research Department, School of Dentistry, Universidad Juárez del Estado de Durango (UJED), 34000 Durango, DGO, Mexico
2Health Care Department, Universidad Autónoma Metropolitana, Xochimilco, 04960 Mexico City, DF, Mexico
3Molecular Pathology Area, School of Dentistry, Universidad de la República (UDELAR), 19200 Montevideo, Uruguay

Received 7 July 2015; Accepted 7 December 2015

Academic Editor: Irene Rebelo

Copyright © 2015 Ramón Gil Carreón-Burciaga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Regezi, “Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws,” Modern Pathology, vol. 15, no. 3, pp. 331–341, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. V. Pinheiro, V. M. Freitas, A. I. S. Moretti, A. G. Jorge, and R. G. Jaeger, “Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity,” Histopathology, vol. 45, no. 1, pp. 65–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Reichart, H. P. Philipsen, and S. Sonner, “Ameloblastoma: biological profile of 3677 cases,” European Journal of Cancer Part B: Oral Oncology, vol. 31, no. 2, pp. 86–99, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. MacDonald-Jankowski, R. Yeung, K. M. Lee, and T. K. Li, “Ameloblastoma in the Hong Kong Chinese. Part 2: systematic review and radiological presentation,” Dentomaxillofacial Radiology, vol. 33, no. 3, pp. 141–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Dhanuthai, S. Chantarangsu, S. Rojanawatsirivej et al., “Ameloblastoma: a multicentric study,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 113, no. 6, pp. 782–788, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Ledesma-Montes, A. Mosqueda-Taylor, R. Carlos-Bregni et al., “Ameloblastomas: a regional Latin-American multicentric study,” Oral Diseases, vol. 13, no. 3, pp. 303–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. “Ameloblastoma,” in World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours, L. Barnes, J. W. Eveson, P. Reichart, and D. Sidransky, Eds., pp. 287–293, IARC Press, Lyon, France, 2005.
  8. P. J. Van Diest, G. Brugal, and J. P. A. Baak, “Proliferation markers in tumours: interpretation and clinical value,” Journal of Clinical Pathology, vol. 51, no. 10, pp. 716–724, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Tumuluri, G. A. Thomas, and I. S. Fraser, “Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma,” Journal of Oral Pathology and Medicine, vol. 31, no. 10, pp. 598–604, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Bologna-Molina, A. Mosqueda-Taylor, N. Molina-Frechero, A.-D. Mori-Estevez, and G. Sánchez-Acuña, “Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 18, no. 2, pp. e174–e179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Maiorano, M. Lutzmann, and M. Méchali, “MCM proteins and DNA replication,” Current Opinion in Cell Biology, vol. 18, no. 2, pp. 130–136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Das, S. B. Prasad, S. S. Yadav et al., “Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis,” PLoS ONE, vol. 8, no. 7, Article ID e69607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Ishibashi, T. Kinugasa, Y. Akagi et al., “Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with dukes C colorectal cancer,” Anticancer Research, vol. 34, no. 8, pp. 4569–4575, 2014. View at Google Scholar · View at Scopus
  14. M. L. Bochman and A. Schwacha, “Differences in the single-stranded DNA binding activities of MCM2-7 and MCM467:MCM2 and MCM5 define a slow ATP-dependent step,” The Journal of Biological Chemistry, vol. 282, no. 46, pp. 33795–33804, 2007. View at Google Scholar
  15. D. Remus, F. Beuron, G. Tolun, J. D. Griffith, E. P. Morris, and J. F. X. Diffley, “Concerted loading of Mcm2-7 double hexamers around DNA during DNA replication origin licensing,” Cell, vol. 139, no. 4, pp. 719–730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Guzińska-Ustymowicz, A. Pryczynicz, A. Kemona, and J. Czyzewska, “Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer,” Anticancer Research, vol. 29, no. 8, pp. 3049–3052, 2009. View at Google Scholar · View at Scopus
  17. B. A. Benevenuto de Andrade, J. E. León, R. Carlos, W. Delgado-Azañero, A. Mosqueda-Taylor, and O. P. De Almeida, “Expression of minichromosome maintenance 2, Ki-67, and geminin in oral nevi and melanoma,” Annals of Diagnostic Pathology, vol. 17, no. 1, pp. 32–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Otero, S. Q. C. Lourenço, I. Ruiz-Ávila et al., “Expression of proliferative markers in ameloblastomas and malignant odontogenic tumors,” Oral Diseases, vol. 19, no. 4, pp. 360–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Bologna-Molina, A. Mosqueda-Taylor, E. Lopez-Corella et al., “Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas,” Oral Oncology, vol. 44, no. 8, pp. 805–811, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Abdel-Aziz and M. M. Amin, “EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence,” Diagnostic Pathology, vol. 7, no. 1, article 14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Metgud and K. Gupta, “Expression of cell cycle and apoptosis-related proteins in ameloblastoma and keratocystic odontogenic tumor,” Annals of Diagnostic Pathology, vol. 17, no. 6, pp. 518–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Bologna-Molina, P. Damián-Matsumura, and N. Molina-Frechero, “An easy cell counting method for immunohistochemistry that does not use an image analysis program,” Histopathology, vol. 59, no. 4, pp. 801–803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. González-González, N. Molina-Frechero, P. Damian-Matsumura, and R. Bologna-Molina, “Molecular markers of cell adhesion in ameloblastomas. An update,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 19, no. 1, pp. e8–e14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Iakovou, E. Chrysomali, E. Piperi et al., “A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma,” Journal of Oral Pathology & Medicine, vol. 44, no. 7, pp. 543–551, 2015. View at Publisher · View at Google Scholar
  25. C. H. Siar, H. Tsujigiwa, I. Ishak, N. M. Hussin, H. Nagatsuka, and K. H. Ng, “RANK, RANKL, and OPG in recurrent solid/multicystic ameloblastoma: their distribution patterns and biologic significance,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 119, no. 1, pp. 83–91, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. R. González-González, N. Molina-Frechero, P. Damian-Matsumura, S. Salazar-Rodriguez, and R. Bologna-Molina, “Immunohistochemical expression of survivin and its relationship with cell apoptosis and proliferation in ameloblastomas,” Disease Markers, vol. 2015, Article ID 301781, 7 pages, 2015. View at Publisher · View at Google Scholar
  27. C. Rizzardi, P. Leocata, L. Ventura et al., “Apoptosis-related factors (TRAIL, DR4, DR5, DcRl, DcR2, apoptotic cells) and proliferative activity in ameloblastomas,” Anticancer Research, vol. 29, no. 4, pp. 1137–1142, 2009. View at Google Scholar · View at Scopus
  28. K. J. Kurppa, J. Catón, P. R. Morgan et al., “High frequency of BRAF V600E mutations in ameloblastoma,” Journal of Pathology, vol. 232, no. 5, pp. 492–498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Migaldi, G. Sartori, G. Rossi, A. Cittadini, and A. Sgambato, “Tumor cell proliferation and microsatellite alterations in human ameloblastoma,” Oral Oncology, vol. 44, no. 1, pp. 50–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. A. Olimid, A. M. Florescu, D. Cernea et al., “The evaluation of p16 and ki67 immunoexpression in ameloblastomas,” Romanian Journal of Morphology and Embryology, vol. 55, no. 2, pp. 363–367, 2014. View at Google Scholar · View at Scopus
  31. M. P. Chae, N. R. Smoll, D. J. Hunter-Smith, W. M. Rozen, and M. Elsalanty, “Establishing the natural history and growth rate of ameloblastoma with implications for management: systematic review and meta-analysis,” PLOS ONE, vol. 10, no. 2, Article ID e0117241, 2015. View at Publisher · View at Google Scholar
  32. A. C. McClary, R. B. West, A. C. McClary et al., “Ameloblastoma: a clinical review and trends in management,” European Archives of Oto-Rhino-Laryngology, In press.
  33. F. Sandra, T. Mitsuyasu, N. Nakamura, Y. Shiratsuchi, and M. Ohishi, “Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma,” Oral Oncology, vol. 37, no. 2, pp. 193–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Meer, J. S. Galpin, M. Altini, H. Coleman, and H. Ali, “Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 95, no. 2, pp. 213–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Hegab, M. Shuman, M. Abd El-Akher, and D. Arwlan, “Ki-67 immunohistochemical expression in mandibular ameloblastoma: a prognostic indicator for local recurrence,” Open Journal of Stomatology, vol. 3, no. 9, pp. 520–526, 2013. View at Publisher · View at Google Scholar
  36. M. A. Kuipers, T. J. Stasevich, T. Sasaki et al., “Highly stable loading of Mcm proteins onto chromatin in living cells requires replication to unload,” The Journal of Cell Biology, vol. 192, no. 1, pp. 29–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. A. Braun and L. L. Breeden, “Nascent transcription of MCM2-7 is important for nuclear localization of the minichromosome maintenance complex in G1,” Molecular Biology of the Cell, vol. 18, no. 4, pp. 1447–1456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. N. E. Simon and A. Schwacha, “The Mcm2-7 replicative helicase: a promising chemotherapeutic target,” BioMed Research International, vol. 2014, Article ID 549719, 14 pages, 2014. View at Publisher · View at Google Scholar
  39. E. Endl, I. Kausch, M. Baack, R. Knippers, J. Gerdes, and T. Scholzen, “The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells,” The Journal of Pathology, vol. 195, no. 4, pp. 457–462, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. A. G. Lameira, F. S. C. Pontes, D. M. Guimarães et al., “MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study,” Journal of Oral Pathology and Medicine, vol. 43, no. 6, pp. 427–434, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. S. Lee, S.-A. Ha, H. J. Kim et al., “Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma,” Experimental and Molecular Pathology, vol. 88, no. 1, pp. 138–142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. S. L. Lau and N. Samman, “Recurrence related to treatment modalities of unicystic ameloblastoma: a systematic review,” International Journal of Oral and Maxillofacial Surgery, vol. 35, no. 8, pp. 681–690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. G. N. Antonoglou and G. K. Sándor, “Recurrence rates of intraosseous ameloblastomas of the jaws: a systematic review of conservative versus aggressive treatment approaches and meta-analysis of non-randomized studies,” Journal of Cranio-Maxillofacial Surgery, vol. 43, no. 1, pp. 149–157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. H.-J. Yoon, B.-C. Jo, W.-J. Shin et al., “Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 112, no. 6, pp. 767–776, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Bologna-Molina, A. Mosqueda-Taylor, E. Lopez-Corella et al., “Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma,” Pathology International, vol. 59, no. 4, pp. 229–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. K.-M. Lau, Q. K. Y. Chan, J. C. S. Pang et al., “Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion,” Oncogene, vol. 29, no. 40, pp. 5475–5489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Kodani, M. Osaki, K. Shomori et al., “Minichromosome maintenance 2 expression is correlated with mode of invasion and prognosis in oral squamous cell carcinomas,” Journal of Oral Pathology and Medicine, vol. 32, no. 8, pp. 468–474, 2003. View at Publisher · View at Google Scholar · View at Scopus